Literature DB >> 16369235

Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.

Rachna Gupta1, S K Gupta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16369235      PMCID： PMC1681678     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  10 in total

1.  Aminotransferase levels during treatment of rheumatoid arthritis with leflunomide in clinical practice.

Authors:  A Hoi; G O Littlejohn
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

Review 2.  [Methotrexate, liver and rheumatoid arthritis in tropical areas].

Authors:  M L Diouf; S Diallo; M Mbengue; T Moreira-Diop
Journal:  Sante       Date:  2001 Jul-Sep

Review 3.  Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

Authors:  J M Kremer
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

4.  Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.

Authors:  W J Shergy; R P Polisson; D S Caldwell; J R Rice; D S Pisetsky; N B Allen
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

5.  Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

Authors:  V Strand; S Cohen; M Schiff; A Weaver; R Fleischmann; G Cannon; R Fox; L Moreland; N Olsen; D Furst; J Caldwell; J Kaine; J Sharp; F Hurley; I Loew-Friedrich
Journal:  Arch Intern Med       Date:  1999-11-22

6.  Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.

Authors:  M E Weinblatt; J M Kremer; J S Coblyn; A L Maier; S M Helfgott; M Morrell; V M Byrne; M V Kaymakcian; V Strand
Journal:  Arthritis Rheum       Date:  1999-07

7.  A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

Authors:  P Emery; F C Breedveld; E M Lemmel; J P Kaltwasser; P T Dawes; B Gömör; F Van Den Bosch; D Nordström; O Bjorneboe; R Dahl; K Horslev-Petersen; A Rodriguez De La Serna; M Molloy; M Tikly; C Oed; R Rosenburg; I Loew-Friedrich
Journal:  Rheumatology (Oxford)       Date:  2000-06       Impact factor: 7.580

8.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

9.  The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.

Authors:  J R Kalden; M Schattenkirchner; H Sörensen; P Emery; C Deighton; B Rozman; F Breedveld
Journal:  Arthritis Rheum       Date:  2003-06

10.  Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study.

Authors:  V Mladenovic; Z Domljan; B Rozman; I Jajic; D Mihajlovic; J Dordevic; M Popovic; M Dimitrijevic; M Zivkovic; G Campion
Journal:  Arthritis Rheum       Date:  1995-11
  10 in total
  3 in total

1.  Prevalence of Aminotransferase Macroenzymes in Rheumatoid Arthritis Patients and Impact on Their Management.

Authors:  Maja Šimac; Daniel Victor Šimac; Lidija Bilić-Zulle
Journal:  EJIFCC       Date:  2021-06-29

2.  Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.

Authors:  Nicolae Leca; Kimberly A Muczynski; Jonathan A Jefferson; Ian H de Boer; Jolanta Kowalewska; Elizabeth A Kendrick; Raimund Pichler; Connie L Davis
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-27       Impact factor: 8.237

Review 3.  Basic Mechanisms of JAK Inhibition.

Authors:  Chung Ma Lin; Faye Ah Cooles; John D Isaacs
Journal:  Mediterr J Rheumatol       Date:  2020-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.